The Babraham Institute undertakes world-leading research into understanding the biology of how our bodies work, including what changes as we age and during disease. Our research is split into three programmes: Epigenetics, Signalling, and Immunology, supported by strategic programme grants from the Biotechnology and Biological Sciences Research Council (BBSRC) and additional funding from research councils, the EU and charities.
We maximise the impact of our research through Knowledge Exchange, Commercialisation and Public Engagement activities. We do this by collaborating with other academics, policy makers, charities, schools, the general public and industry, including companies on the Babraham Research Campus. Commercialisation is achieved in collaboration with the Institute’s wholly-owned trading arm, Babraham Institute Enterprise Limited.
Access our Science Facilities
Providing biological computing services for the research groups at the institute and for external users.
The Imaging Facility provides supported access to advanced imaging technologies and image analysis solutions
We offer sequencing and library preparation services that are tailored to suit research needs. Our Facility is also open for external users on a fee-for-service basis.
Our state-of-the-art Biological Support Unit provides housing and care for pathogen-free rodents. It supports research across the Institute as well as providing services
The Lipidomics Facility undertakes the detection and identification of lipids, with a focus on providing biological meaning to these generated lipid profiles through bios
To provide a research interface between chemistry and biology to solve biological questions.
The Babraham Institute Flow Cytometry Core Facility offers high quality service and state-of-the-art instrumentation to members of Babraham Institute and external users.
The primary role of the Facility is to apply state of the art techniques in mass spectrometry to address important biological questions, within the remit of the Institute
To deliver gene targeting capabilities including the production of transgenic mouse models. The gene targeting facility aims to enable Babraham Institute scientists to
Members of the public may wish to look at the following pages to find out how the Babraham Institute works with and for society:
Polypyrimidine Tract Binding Protein 1 regulates the activation of mouse CD8 T cells.
D'Angeli V, Monzón-Casanova E, Matheson LS,
European journal of immunology
1
1:
22 Apr 2022
PMID: 35460072
A functional screen of RNA binding proteins identifies genes that promote or limit the accumulation of CD138+ plasma cells.
Turner DJ, Saveliev A, Salerno F,
eLife
11
1:
22 Apr 2022
PMID: 35451955